Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Harold Hatch"'
Autor:
Robert N Booher, Harold Hatch, Brian M Dolinski, Thi Nguyen, Lauren Harmonay, Ali-Samer Al-Assaad, Mark Ayers, Michael Nebozhyn, Andrey Loboda, Heather A Hirsch, Theresa Zhang, Bin Shi, Carrie E Merkel, Minilik H Angagaw, Yaolin Wang, Brian J Long, Xianlu Q Lennon, Nathan Miselis, Vincenzo Pucci, James W Monahan, Junghoon Lee, Anna Georgieva Kondic, Eun Kyung Im, David Mauro, Rebecca Blanchard, Gary Gilliland, Stephen E Fawell, Leigh Zawel, Alwin G Schuller, Peter Strack
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e108371 (2014)
Dinaciclib is a potent CDK1, 2, 5 and 9 inhibitor being developed for the treatment of cancer. Additional understanding of antitumor mechanisms and identification of predictive biomarkers are important for its clinical development. Here we demonstrat
Externí odkaz:
https://doaj.org/article/b410584fec734e0e84be6d52d5590862
Autor:
Hidehito Kotani, Bo-Sheng Pan, Pradip K. Majumder, Harold Hatch, Yoko Ueno, Kyoko Tsujioka, Shunsuke Taguchi, Katsuyoshi Miyama, Yoko Nakatsuru, Hiroshi Sootome, Hiroshi Hirai
Supplementary Data from MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2de18f2eea7f6ca1d5c2c31985f304cd
https://doi.org/10.1158/1535-7163.22486085.v1
https://doi.org/10.1158/1535-7163.22486085.v1
Autor:
Christopher J. Dinsmore, Nancy E. Kohl, Qinwen Zeng, Alexander A. Szewczak, John F. Reilly, Xianlu Qu, Cloud P. Paweletz, Bart A. Lutterbach, Wei Lu, Kaiko Kunii, Jason D. Katz, Ilona Kariv, James P. Jewell, Harold Hatch, Gaozhen Hang, Susana Gil, Jackson B. Gibbs, Sujal V. Deshmukh, Lenora J. Davis, An Chi, Melissa Chenard, Grace K.Y. Chan, Bo-Sheng Pan
Supplementary Figure 3 from MK-2461, a Novel Multitargeted Kinase Inhibitor, Preferentially Inhibits the Activated c-Met Receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37ead8a2c84ec1e9b5c7fd484d5aa73e
https://doi.org/10.1158/0008-5472.22383779
https://doi.org/10.1158/0008-5472.22383779
Autor:
Christopher J. Dinsmore, Nancy E. Kohl, Qinwen Zeng, Alexander A. Szewczak, John F. Reilly, Xianlu Qu, Cloud P. Paweletz, Bart A. Lutterbach, Wei Lu, Kaiko Kunii, Jason D. Katz, Ilona Kariv, James P. Jewell, Harold Hatch, Gaozhen Hang, Susana Gil, Jackson B. Gibbs, Sujal V. Deshmukh, Lenora J. Davis, An Chi, Melissa Chenard, Grace K.Y. Chan, Bo-Sheng Pan
Supplementary Figure 4 from MK-2461, a Novel Multitargeted Kinase Inhibitor, Preferentially Inhibits the Activated c-Met Receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::054140e8884713105eec245eadc1cdda
https://doi.org/10.1158/0008-5472.22383776
https://doi.org/10.1158/0008-5472.22383776
Autor:
Christopher J. Dinsmore, Nancy E. Kohl, Qinwen Zeng, Alexander A. Szewczak, John F. Reilly, Xianlu Qu, Cloud P. Paweletz, Bart A. Lutterbach, Wei Lu, Kaiko Kunii, Jason D. Katz, Ilona Kariv, James P. Jewell, Harold Hatch, Gaozhen Hang, Susana Gil, Jackson B. Gibbs, Sujal V. Deshmukh, Lenora J. Davis, An Chi, Melissa Chenard, Grace K.Y. Chan, Bo-Sheng Pan
Supplementary Figure 2 from MK-2461, a Novel Multitargeted Kinase Inhibitor, Preferentially Inhibits the Activated c-Met Receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a65a09f92681267a6de3aaaa88df405
https://doi.org/10.1158/0008-5472.22383782
https://doi.org/10.1158/0008-5472.22383782
Autor:
Christopher J. Dinsmore, Nancy E. Kohl, Qinwen Zeng, Alexander A. Szewczak, John F. Reilly, Xianlu Qu, Cloud P. Paweletz, Bart A. Lutterbach, Wei Lu, Kaiko Kunii, Jason D. Katz, Ilona Kariv, James P. Jewell, Harold Hatch, Gaozhen Hang, Susana Gil, Jackson B. Gibbs, Sujal V. Deshmukh, Lenora J. Davis, An Chi, Melissa Chenard, Grace K.Y. Chan, Bo-Sheng Pan
Supplementary Figure 1 from MK-2461, a Novel Multitargeted Kinase Inhibitor, Preferentially Inhibits the Activated c-Met Receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72d584751769fb485b613b5d4da0b8ad
https://doi.org/10.1158/0008-5472.22383785
https://doi.org/10.1158/0008-5472.22383785
Autor:
Christopher J. Dinsmore, Nancy E. Kohl, Qinwen Zeng, Alexander A. Szewczak, John F. Reilly, Xianlu Qu, Cloud P. Paweletz, Bart A. Lutterbach, Wei Lu, Kaiko Kunii, Jason D. Katz, Ilona Kariv, James P. Jewell, Harold Hatch, Gaozhen Hang, Susana Gil, Jackson B. Gibbs, Sujal V. Deshmukh, Lenora J. Davis, An Chi, Melissa Chenard, Grace K.Y. Chan, Bo-Sheng Pan
Supplementary Figure 5 from MK-2461, a Novel Multitargeted Kinase Inhibitor, Preferentially Inhibits the Activated c-Met Receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::698732c4b28be2c0e774afa90e7f46c3
https://doi.org/10.1158/0008-5472.22383773.v1
https://doi.org/10.1158/0008-5472.22383773.v1
Autor:
Bo-Sheng Pan, Jackson B. Gibbs, Nancy E. Kohl, Gaozhen Hang, Harold Hatch, Lenora J. Davis, Qinwen Zeng, Bart Lutterbach
Supplementary Figure 1 Legend from Lung Cancer Cell Lines Harboring MET Gene Amplification Are Dependent on Met for Growth and Survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::853ef100f21a4c3b3b227e6e42d0c3d8
https://doi.org/10.1158/0008-5472.22368666.v1
https://doi.org/10.1158/0008-5472.22368666.v1
Autor:
Bart Lutterbach, Cem Elbi, Alessandra Di Bacco, Masakazu Yashiro, Harold Hatch, Julie Gorenstein, Lenora Davis, Kaiko Kunii
We have identified a critical role for amplified FGFR2 in gastric cancer cell proliferation and survival. In a panel of gastric cancer cell lines, fibroblast growth factor receptor 2 (FGFR2) was overexpressed and tyrosine phosphorylated selectively i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47db3f833a134adf73f50cc43e6171a7
https://doi.org/10.1158/0008-5472.c.6497708
https://doi.org/10.1158/0008-5472.c.6497708
Autor:
Bart Lutterbach, Cem Elbi, Alessandra Di Bacco, Masakazu Yashiro, Harold Hatch, Julie Gorenstein, Lenora Davis, Kaiko Kunii
Supplementary Figures 1-10 from FGFR2-Amplified Gastric Cancer Cell Lines Require FGFR2 and Erbb3 Signaling for Growth and Survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41777d8fd16e16d9fdbcb66fa62325dd
https://doi.org/10.1158/0008-5472.22375091
https://doi.org/10.1158/0008-5472.22375091